Evidence supports the use of hydrocortisone for patients with community-acquired pneumonia.

Lu, De-En; Chang, Cheng-Yi; Cheng, Sheng-Wei; Kang, Enoch; Lee, Chih-Hsin; Chen, Kee-Hsin

Lu, De-En; Chang, Cheng-Yi; Cheng, Sheng-Wei; Kang, Enoch; Lee, Chih-Hsin; Chen, Kee-Hsin.

Afiliação

Lu DE; Division of Nephrology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
Chang CY; Division of General Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
Cheng SW; Division of General Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
Kang E; Division of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
Lee CH; Cochrane Taiwan, Taipei Medical University, Taipei, Taiwan.
Chen KH; Evidence-Based Medicine Center, Wan Fang Hospital, Medical University Hospital, Taipei, Taiwan.

Crit Care ; 28(1): 55, 2024 02 20.

Article em En | MEDLINE | ID: mdl-38378580

Assuntos

Infecções Comunitárias Adquiridas; Hidrocortisona; Pneumonia; Humanos; Infecções Comunitárias Adquiridas/tratamento farmacológico; Hidrocortisona/uso terapêutico; Pneumonia/tratamento farmacológico; Resultado do Tratamento

Palavras-chave

CAP; Community-acquired pneumonia; Corticosteroids; Intensive care unit; Steroids

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia / Hidrocortisona / Infecções Comunitárias Adquiridas Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google